Cortechs.ai | NeuroQuant 2.0 Just Got Better

NeuroQuant 2.0 Just Got Better

Cortechs.ai | NeuroQuant 2.0 Just Got Better3 New Reports Available With NeuroQuant 2.0

Familiarize yourself with our three brand new NeuroQuant reports – Multi Structure Atrophy, Triage Brain Atrophy, and Brain Development Reports.

Multi Structure Atrophy Report 

  • Helpful in an atrophied brain with a high lesion burden, such as is seen in forms of Multiple Sclerosis and age associated neurodegenerative conditions.
  • Gives total brain volume, white and gray matter, thalamus and more measurements compared to age and gender matched norms.
  • Designated Report Color – Green
  • Easy recognition of reports sorted by color

Triage Brain Report

  • Multiple volume measurements sorted by lobe and brain structure sub-regions affected by trauma
  • Indicates right and left values for Z-score and normative percentile of ICV of 39 brain structures
  • Designated Report Color – Red
  • Easy recognition of reports sorted by color

Brain Development Report

  • Helpful in the assessment of pediatric brain development
  • Forebrain parenchyma and lateral ventricles for age norms 3 and up
  • Designated Report Color – Purple
  • Easy recognition of reports sorted by color

Want to learn even more about NeuroQuant 2.0? Click here to read more about NeuroQuant 2.0 features and benefits or register below to watch the following webinars:

  1. Familiarize Yourself with NeuroQuant 2.0, hosted by Chris Airriess, Chief Technology Officer, Cortechs.ai – June 11th
  2. NeuroQuant 2.0 for Neurodegenerative Assessment,hosted by Dr. James Brewer, UC San Diego – June 17th

More Resources

03/13/2026

Cortechs Cares: Community Impact and Volunteer Efforts in 2025

Cortechs Cares highlights how our team gave back in 2025 through community volunteer efforts, including an Alzheimer’s Walk and holiday toy drive.

03/11/2026

OnQ™ Prostate: Bringing Quantitative MRI to Prostate Imaging

Advancing prostate MRI with quantitative diffusion biomarkers. OnQ™ Prostate brings objective RSI-based insights to support data-driven cancer evaluation.

03/04/2026

Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies

NeuroQuant® Lesion Surveillance will be integrated into the Siemens Healthineers Digital Marketplace to advance quantitative brain imaging worldwide.

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

02/24/2026

Financial Conflict Of Interest Policy Applicable To NIH Awards

02/20/2026

NeuroQuant® PET: FDA 510(k)-Pending Advancement in Molecular Dementia Imaging

FDA 510(k)-Pending NeuroQuant® PET delivers automated, standardized quantification for amyloid, tau, and FDG imaging in dementia care.
Scroll to Top